177 related articles for article (PubMed ID: 36232947)
41. Antibacterial Activity and Antibiotic-Enhancing Effects of Honeybee Venom against Methicillin-Resistant Staphylococcus aureus.
Han SM; Kim JM; Hong IP; Woo SO; Kim SG; Jang HR; Pak SC
Molecules; 2016 Jan; 21(1):79. PubMed ID: 26771592
[TBL] [Abstract][Full Text] [Related]
42. Antibacterial and herbicidal activity of ring-substituted 2-hydroxynaphthalene-1-carboxanilides.
Gonec T; Kos J; Zadrazilova I; Pesko M; Govender R; Keltosova S; Chambel B; Pereira D; Kollar P; Imramovsky A; O'Mahony J; Coffey A; Cizek A; Kralova K; Jampilek J
Molecules; 2013 Aug; 18(8):9397-419. PubMed ID: 23924993
[TBL] [Abstract][Full Text] [Related]
43. Antimicrobial and antitumor activity of peptidomimetics synthesized from amino acids.
Li H; Fu S; Wang Y; Yuan X; Liu L; Dong H; Wang Q; Zhang Z
Bioorg Chem; 2021 Jan; 106():104506. PubMed ID: 33276980
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
Krátký M; Volková M; Novotná E; Trejtnar F; Stolaříková J; Vinšová J
Bioorg Med Chem; 2014 Aug; 22(15):4073-82. PubMed ID: 24953953
[TBL] [Abstract][Full Text] [Related]
45. Discovery of quinolinequinones with N-phenylpiperazine by conversion of hydroxyquinoline as a new class of antimicrobial agents targeting resistant pathogenic microorganisms.
Yıldız M; Bayrak N; Yıldırım H; Çakmak SM; Yılmaz FN; Mataracı-Kara E; Shilkar D; Jayaprakash V; TuYuN AF
Bioorg Chem; 2022 Nov; 128():106045. PubMed ID: 35921788
[TBL] [Abstract][Full Text] [Related]
46. Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.
Afshari A; Taheri S; Hashemi M; Norouzy A; Nematy M; Mohamadi S
Curr Microbiol; 2022 Sep; 79(11):326. PubMed ID: 36125553
[TBL] [Abstract][Full Text] [Related]
47. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
Yoneda A; Thänert R; Burnham CD; Dantas G
Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
[TBL] [Abstract][Full Text] [Related]
48. Antistaphylococcal activity of oritavancin and its synergistic effect in combination with other antimicrobial agents.
Lin G; Pankuch G; Appelbaum PC; Kosowska-Shick K
Antimicrob Agents Chemother; 2014 Oct; 58(10):6251-4. PubMed ID: 25022588
[TBL] [Abstract][Full Text] [Related]
49. The Synthesis and Biological Evaluation of 2-(1
Mendogralo EY; Nesterova LY; Nasibullina ER; Shcherbakov RO; Tkachenko AG; Sidorov RY; Sukonnikov MA; Skvortsov DA; Uchuskin MG
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513221
[TBL] [Abstract][Full Text] [Related]
50. Methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium active dimeric isobutyrylphloroglucinol from Ivesia gordonii.
Ahmed MH; Ibrahim MA; Zhang J; Melek FR; El-Hawary SS; Jacob MR; Muhammad I
Nat Prod Commun; 2014 Feb; 9(2):221-4. PubMed ID: 24689296
[TBL] [Abstract][Full Text] [Related]
51. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents.
Imramovský A; Vinsová J; Férriz JM; Buchta V; Jampílek J
Bioorg Med Chem Lett; 2009 Jan; 19(2):348-51. PubMed ID: 19081718
[TBL] [Abstract][Full Text] [Related]
52. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S
Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides.
Servusova-Vanaskova B; Paterova P; Garaj V; Mandikova J; Kunes J; Naesens L; Jílek P; Dolezal M; Zitko J
Chem Biol Drug Des; 2015 Oct; 86(4):674-81. PubMed ID: 25676890
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC
Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036
[TBL] [Abstract][Full Text] [Related]
55. Antibacterial Properties of Four Novel Hit Compounds from a Methicillin-Resistant Staphylococcus aureus-Caenorhabditis elegans High-Throughput Screen.
Tharmalingam N; Rajmuthiah R; Kim W; Fuchs BB; Jeyamani E; Kelso MJ; Mylonakis E
Microb Drug Resist; 2018 Jun; 24(5):666-674. PubMed ID: 29461939
[TBL] [Abstract][Full Text] [Related]
56. Ring-substituted 8-hydroxyquinoline-2-carboxanilides as potential antimycobacterial agents.
Kos J; Zadrazilova I; Nevin E; Soral M; Gonec T; Kollar P; Oravec M; Coffey A; O'Mahony J; Liptaj T; Kralova K; Jampilek J
Bioorg Med Chem; 2015 Aug; 23(15):4188-4196. PubMed ID: 26183541
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and In Vitro Antimycobacterial Activity of Novel N-Arylpiperazines Containing an Ethane-1,2-diyl Connecting Chain.
Goněc T; Malík I; Csöllei J; Jampílek J; Stolaříková J; Solovič I; Mikuš P; Keltošová S; Kollár P; O'Mahony J; Coffey A
Molecules; 2017 Nov; 22(12):. PubMed ID: 29189762
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
59. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Shahin IG; Abutaleb NS; Alhashimi M; Kassab AE; Mohamed KO; Taher AT; Seleem MN; Mayhoub AS
Eur J Med Chem; 2020 Sep; 202():112497. PubMed ID: 32707373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
